This exhibit includes portions from the previously published Results Announcement of Barclays PLC relating to the nine months ended 30 September 2023, as amended in part to comply with the requirements of Regulation G and Item 10(e) of Regulation S-K promulgated by the US Securities and Exchange Commission (SEC), including the reconciliation of certain financial information to comparable measures prepared in accordance with International Financial Reporting Standards (IFRS). The purpose of this document is to provide such additional disclosure as required by Regulation G and Regulation S-K item 10(e), to delete certain information not in compliance with SEC regulations and to include reconciliations of certain non-IFRS figures to the most directly equivalent IFRS figures for the periods presented. This document does not update or otherwise supplement the information contained in the previously published Results Announcement. Any reference to a website in this document is made for informational purposes only, and information found at such websites is not incorporated by reference into this document.

An audit opinion has not been rendered in respect of this document.

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the nine months ended 30 September 2023 to the corresponding nine months of 2022 and balance sheet analysis as at 30 September 2023 with comparatives relating to 31 December 2022 and 30 September 2022. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.

The information in this announcement, which was approved by the Board of Directors on 23 October 2023, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2022, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 41 to 47 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.

Key non-IFRS measures included in this document, and the most directly comparable IFRS measures, are:

– Average allocated equity represents the average shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is average equity. A reconciliation is provided on pages 44 to 45;

– Average allocated tangible equity (for businesses) is calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. Period end allocated tangible equity is calculated as 13.5% (2022: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group’s tangible shareholders’ equity and the amounts allocated to businesses. The comparable IFRS measure is average equity. A reconciliation is provided on pages 44 to 45;

– Average tangible shareholders’ equity (for Barclays Group) is calculated as the average of the previous month’s period end tangible shareholders' equity and the current month’s period end tangible shareholders' equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period. The comparable IFRS measure is average equity. A reconciliation is provided on pages 44 to 45;

– Group operating expenses excluding litigation and conduct represents Group operating expenses excluding litigation and conduct charges. The comparable IFRS measure is total operating expenses;

– Income excluding the Over-issuance of Securities represents total income excluding the impact of the Over-issuance of Securities. The comparable IFRS measure is Total income. A reconciliation is provided on page 42;

– Operating expenses excluding the Over-issuance of Securities represents total Operating expenses excluding the impact of the Over-issuance of Securities. The comparable IFRS measure is Total operating expenses. A reconciliation is provided on page 42;

– Return on average allocated equity represents the return on shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is return on equity. A reconciliation is provided on page 47;

– Return on average allocated tangible equity (for businesses) is calculated as annualised Group attributable profit, as a proportion of average shareholders’ tangible equity. The comparable IFRS measure is return on equity. A reconciliation is provided on pages 44 to 45;

– Return on average tangible shareholders’ equity (for Barclays Group) is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The comparable IFRS measure is return on equity. A reconciliation is provided on page 41; and

– Tangible net asset value per share is calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The comparable IFRS measure is net asset value per share. A reconciliation is provided on page 46.

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income levels, costs, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend policy and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the policies and actions of governmental and regulatory authorities; the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group’s control; the impact of competition; capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine war on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and any disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the US Securities and Exchange Commission (SEC) (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial year ended 31 December 2022 and Interim Results Announcement for the six months ended 30 June 2023 filed on Form 6-K), which are available on the SEC’s website at www.sec.gov.

Subject to Barclays PLC’s obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

•Q323 Group RoE of 9.3% and RoTE of 11.0% and Q323 YTD Group RoE of 10.5% and RoTE of 12.5%. Barclays UK Q323 RoE of 15.2% and RoTE of 21.0% and Barclays UK Q323 YTD RoE of 15.0% and RoTE of 20.6%

•Prudent risk management with Q323 YTD loan loss rate (LLR) of 43bps

•Strong balance sheet with CET1 ratio of 14.0%

•c.7.5p total distributions per share announced at H123: dividend of 2.7p now paid, and share buyback of £750m completed

•Group RoE of 9.3% and RoTE of 11.0% with profit before tax of £1.9bn (Q322: £2.0bn).

•Including the impacts from the Over-issuance of Securities1,2 in the prior year

◦Group income up 5% year-on-year to £6.3bn

◦Barclays UK income decreased 2% to £1.9bn

◦Corporate and Investment Bank (CIB) income increased 9% to £3.1bn

◦Consumer, Cards and Payments (CC&P) income increased 9% to £1.4bn

•Group total operating expenses decreased 10% to £4.0bn

•Excluding these impacts:

–Group income down 2% year-on-year to £6.3bn:

–Barclays UK income decreased 2% to £1.9bn, primarily driven by the impact from the transfer of Wealth Management & Investments (WM&I) to CC&P. Excluding the transfer, Barclays UK income was up 1%3 driven by net interest income growth from higher rates, including continued structural hedge income, partially offset by product dynamics in deposits and mortgages

–CIB income decreased 6% to £3.1bn, reflecting lower client activity in both Global Markets (against a record FICC performance in Q3224) and Investment Banking fees, more than offsetting higher Corporate income from higher rates and the non-repeat of fair value losses on leverage finance lending in the prior year

–CC&P income increased 9% to £1.4bn reflecting higher balances in US cards and the benefit of the transfer of WM&I from Barclays UK

–Group total operating expenses decreased 4% year-on-year to £3.9bn, as inflation, business growth and investments were more than offset by efficiency savings and lower litigation and conduct charges

•Credit impairment charges were £0.4bn, with an LLR of 42bps

•CET1 ratio of 14.0%, with risk weighted assets (RWAs) of £341.9bn, net asset value (NAV) per share of 370p and tangible net asset value (TNAV) per share of 316p

1Denotes the Over-issuance of Securities under Barclays Bank PLC's US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. See page 42 for a reconciliation of financial results excluding the impact of the Over-issuance of Securities in the prior year.

2Q322 impacts from the Over-Issuance of Securities: £0.5bn income reduction and £0.5bn reduction in litigation and conduct charges.

3The income impact of the WM&I transfer was c.£60m in Q323.

4Q322 was a record third quarter performance for FICC within Global Markets. Period covering Q114-Q323. Pre 2014 data was not restated following re-segmentation in Q116.

•Group RoE was 10.5% (Q322 YTD: 9.3%), RoTE was 12.5% (Q322 YTD: 10.9%) with profit before tax of £6.4bn (Q322 YTD: £5.7bn).

•On a statutory basis:

•Group income was £19.8bn, up 3% year-on-year

•Group total operating expenses were £12.0bn, a decrease of 6% year-on-year

•Cost: income ratio was 61%

•Excluding the impact of the Over-issuance of Securities in the prior year1:

–Group income of £19.8bn, up 5% year-on-year

–Group total operating expenses were £12.0bn, up 2% year-on-year. Cost: income ratio of 61% as the Group delivered positive cost: income jaws of 3%

•Credit impairment charges were £1.3bn with an LLR of 43bps, with delinquencies in US cards in line with pre-pandemic experience

•Costs: targeting a cost: income ratio percentage in the low 60s in 2023, investing for growth whilst progressing towards the Group’s medium-term target of below 60%. Separately, the Group is evaluating actions to reduce structural costs to help drive future returns, which may result in material additional charges in Q423

•Returns: targeting a RoTE2 of greater than 10% in 2023, excluding any such structural costs actions

•Impairment: expect an LLR of 50-60bps through the cycle

•Barclays UK Net Interest Margin (NIM): now expected to be in the range of 3.05% - 3.10% in 2023. Guidance is sensitive to the level and mix of deposit balances and further changes in expectations for interest rates

•Capital: expect to continue to operate within the CET1 ratio target range of 13-14%

•Capital returns: capital distribution policy incorporates a progressive ordinary dividend, supplemented with share buybacks as appropriate

1Denotes the Over-issuance of Securities under Barclays Bank PLC's US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. See page 42 for a reconciliation of financial results excluding the impact of the Over-issuance of Securities. Q322 YTD impacts from the Over-Issuance of Securities: £0.3bn income gain and £1.0bn litigation and conduct charges.

2Management does not assess forward-looking “return on equity” (target RoE) as a performance indicator of the business, and therefore a reconciliation of the forward looking non-IFRS measure “return on tangible equity” (target RoTE) to an equivalent IFRS measure is not available without unreasonable efforts.

Barclays Group results			Nine months ended												Three months ended
			30.09.23			30.09.22									30.09.23			30.09.22
			£m			£m			% Change						£m			£m			% Change
Barclays UK			5,795			5,289			10						1,873			1,916			(2)
Corporate and Investment Bank			10,220			10,792			(5)						3,082			2,821			9
Consumer, Cards and Payments			3,944			3,213			23						1,360			1,244			9
Barclays International			14,164			14,005			1						4,442			4,065			9
Head Office			(179)			(139)			(29)						(57)			(30)			(90)
Total income			19,780			19,155			3						6,258			5,951			5
Operating costs			(11,979)			(11,209)			(7)						(3,949)			(3,939)			—
Litigation and conduct			(32)			(1,518)			98						—			339
Total operating expenses			(12,011)			(12,727)			6						(3,949)			(3,600)			(10)
Other net income/(expenses)			7			(4)									9			(1)
Profit before impairment			7,776			6,424			21						2,318			2,350			(1)
Credit impairment charges			(1,329)			(722)			(84)						(433)			(381)			(14)
Profit before tax			6,447			5,702			13						1,885			1,969			(4)
Tax charge			(1,257)			(1,072)			(17)						(343)			(249)			(38)
Profit after tax			5,190			4,630			12						1,542			1,720			(10)
Non-controlling interests			(39)			(23)			(70)						(9)			(2)
Other equity instrument holders			(766)			(620)			(24)						(259)			(206)			(26)
Attributable profit			4,385			3,987			10						1,274			1,512			(16)
Performance measures
Return on average shareholders' equity			10.5%			9.3%									9.3%			10.6%
Return on average tangible shareholders' equity			12.5%			10.9%									11.0%			12.5%
Average shareholders' equity (£bn)			55.5			56.9									55.1			56.8
Average tangible shareholders' equity (£bn)			47.0			48.8									46.5			48.6
Cost: income ratio			61%			66%									63%			60%
Loan loss rate (bps)			43			23									42			36
Basic earnings per share			28.2p			24.2p									8.3p			9.4p
Basic weighted average number of shares (m)			15,564			16,503			(6)						15,405			16,148			(5)
Period end number of shares (m)			15,239			15,888			(4)						15,239			15,888			(4)

			As at 30.09.23						As at 31.12.22						As at 30.09.22
Balance sheet and capital management1			£bn						£bn						£bn
Loans and advances at amortised cost			405.4						398.8						413.7
Loans and advances at amortised cost impairment coverage ratio			1.4%						1.4%						1.4%
Total assets			1,591.7						1,513.7						1,726.9
Deposits at amortised cost			561.3						545.8						574.4
Net asset value per share			370p						347p						338p
Tangible net asset value per share			316p						295p						286p
Common equity tier 1 ratio			14.0%						13.9%						13.8%
Common equity tier 1 capital			48.0						46.9						48.6
Risk weighted assets			341.9						336.5						350.8
UK leverage ratio			5.0%						5.3%						5.0%
UK leverage exposure			1,202.4						1,130.0						1,232.1
Funding and liquidity
Group liquidity pool (£bn)			335.0						318.0						325.8
Liquidity coverage ratio2			159%						156%						156%
Net stable funding ratio3			138%						137%
Loan: deposit ratio			72%						73%						72%

1Refer to pages 33 to 37 for further information on how capital, RWAs and leverage are calculated.

2The Liquidity Coverage Ratio is now shown on an average basis, based on the average of the last 12 spot month end ratios. Prior period LCR comparatives have been updated for consistency.

3Represents average of the last four spot quarter end positions.

•Barclays delivered a profit before tax of £6,447m (Q322 YTD: £5,702m), RoE of 10.5% (Q322 YTD: 9.3%), RoTE of 12.5% (Q322 YTD: 10.9%) and earnings per share (EPS) of 28.2p (Q322 YTD: 24.2p)

•The Group has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses

•Group income increased 3% to £19,780m primarily driven by the net benefit from the higher interest rate environment, including continued structural hedge income, and higher balances in US cards, partially offset by the non repeat of the prior year income from hedging arrangements related to the Over-issuance of Securities and lower income in Global Markets and Investment Banking fees

•Group total operating expenses decreased to £12,011m (Q322 YTD: £12,727m)

–Group operating expenses excluding litigation and conduct charges increased to £11,979m (Q322 YTD: £11,209m) reflecting the impact of business growth, including the Gap portfolio acquisition in US cards and the Kensington Mortgage Company (KMC) acquisition in Barclays UK, as well as investments in resilience and controls. The impact of Group inflation was broadly offset by efficiency savings. The Group incurred £119m of structural cost actions (Q322 YTD: £78m), primarily related to the ongoing Barclays UK transformation programme

–Litigation and conduct charges decreased to £32m (Q322 YTD: £1,518m). The prior year charges included £966m of costs related to the Over-issuance of Securities, £282m of customer remediation costs relating to legacy loan portfolios in CC&P and £165m related to the Devices Settlements1

•Credit impairment charges were £1,329m (Q322 YTD: £722m), with delinquencies in US cards in line with pre-pandemic experience. Total coverage ratio remains strong at 1.4% (December 2022: 1.4%)

•The effective tax rate (ETR) was 19.5% (Q322 YTD: 18.8%). The prior year included tax benefits arising in the year and in respect of prior years, which were partially offset by the impact of the downward re-measurement of the Group's UK deferred tax assets as a result of the UK banking surcharge rate being reduced from 8% to 3%

•Attributable profit was £4,385m (Q322 YTD: £3,987m)

•Total assets increased to £1,591.7bn (December 2022: £1,513.7bn) driven by increased trading activity within CIB since December 2022. The Group liquidity pool was further strengthened by deposit growth

•NAV per share was 370p (December 2022: 347p). TNAV per share increased to 316p (December 2022: 295p) as EPS of 28.2p and the impact of share buybacks announced at FY22 and H123 results were partially offset by dividends paid in the period and net negative reserve movements

Barclays UK delivered a RoE of 15.0% and a RoTE of 20.6% supported by the higher interest rate environment and the continued investment in our transformation into a next-generation, digitised consumer bank. The challenging environment has persisted with customer behaviour driving a reduction in the NIM outlook and balances.

•Profit before tax increased 16% to £2,300m with a RoE of 15.0% (Q322 YTD: 13.8%) and a RoTE of 20.6% (Q322 YTD: 18.7%)

•Total income increased 10% to £5,795m. Net interest income increased 13% to £4,856m with a NIM of 3.15% (Q322 YTD: 2.78%), as higher interest rates and associated structural hedge benefit outweighed mortgage margin pressure, lower deposit volumes and the search for yield in savings, with these product dynamics trends increasing in Q323. Net fee, commission and other income decreased 6% to £939m including the impact of the transfer of WM&I to CC&P

•Personal Banking income increased 11% to £3,662m, driven by higher interest rates, partially offset by mortgage margin compression and lower current accounts deposit volumes consistent with wider market trends and cost of living pressures

•Barclaycard Consumer UK income decreased 12% to £722m as higher customer spend volumes were more than offset by lower interest earning lending balances following repayments and ongoing prudent risk management

•Business Banking income increased 22% to £1,411m driven by higher interest rates, partially offset by lower government scheme lending as repayments continue and lower deposit volumes in line with wider market trends

•Total operating expenses increased 2% to £3,228m from the impact of inflation, partially offset by the transfer of WM&I to CC&P. Ongoing efficiency savings continue to be reinvested, including in our transformation programme to support further improvements to the cost: income ratio over time

•Credit impairment charges increased to £267m (Q322 YTD: £129m), driven by updated macroeconomic scenarios, reflecting year-to-date improvement in GDP and unemployment outlook against a backdrop of higher interest rates and a weaker House Price Index (HPI). UK cards 30 and 90 day arrears remained low at 0.9% (Q322: 1.0%) and 0.2% (Q322: 0.3%) respectively. The UK cards total coverage ratio was 6.3% (December 2022: 7.6%)

1Refers to the settlements with the SEC and Commodity Futures Trading Commission (CFTC) in connection with their investigations of the use of unauthorised devices for business communications.

•Loans and advances to customers at amortised cost were broadly stable at £204.9bn (December 2022: £205.1bn), primarily reflecting the acquisition of KMC and mortgage lending in the first half of the year, which more than offset repayment of government scheme lending in Business Banking

•Customer deposits at amortised cost decreased 6% to £243.2bn. Primarily driven by reduced current account balances in Personal and Business Banking, reflecting broader market trends. The loan: deposit ratio increased to 92% (December 2022: 87%)

–Average balances quarter-on-quarter contributed to a larger net interest income deposit effect than the period end balances

•RWAs were stable at £73.2bn (December 2022: £73.1bn) including a reduction due to a capital Loss Given Default (LGD) model update for the mortgages portfolio, partially offset by the acquisition of KMC

Barclays International delivered a RoE of 11.1% and a RoTE of 11.4%. Despite the reduced banking industry fee pool and lower client activity in Global Markets, CIB delivered a RoE of 11.5% and a RoTE of 11.5% reflecting the benefits of income diversification and investment in sustainable growth. CC&P delivered a RoE of 9.0% and RoTE of 10.6% reflecting continued investment in the business resulting in balance growth and increased income, partially offset by higher impairment charges.

•Profit before tax increased 10% to £4,580m with a RoE of 11.1% (Q322 YTD: 11.3%) and a RoTE of 11.4% (Q322 YTD: 11.5%), reflecting a RoE of 11.5% (Q322 YTD: 11.9%) and a RoTE of 11.5% (Q322 YTD: 11.9%) in CIB and RoE of 9.0% (Q322 YTD: 7.4%) and RoTE of 10.6% (Q322 YTD: 8.9%) in CC&P

•Barclays International has a diverse income profile across businesses and geographies including a significant presence in the US. The appreciation of average USD against GBP positively impacted income and profits, and adversely impacted credit impairment charges and total operating expenses

•Total income increased to £14,164m (Q322 YTD: £14,005m)

–CIB income decreased 5% to £10,220m and 3% excluding the £292m impact from prior year hedging arrangements related to the Over-issuance of Securities1.

–Global Markets income decreased 18% to £6,063m. FICC income decreased 13% to £4,121m, driven by macro reflecting lower market volatility and client activity, partially offset by strong performance in credit. Equities income decreased 28% to £1,942m, driven by a decline in derivatives income reflecting less volatile equity market conditions. Excluding the impact from the Over-issuance of Securities of £292m, Equities income decreased by 20%

–Investment Banking fees decreased 16% to £1,450m due to the reduced fee pool across Advisory and Debt capital markets2, partially offset by an improvement in Equity capital markets

–Within Corporate, Transaction banking income increased 31% to £2,272m driven by improved deposit margins in the higher interest rate environment. Corporate lending income increased to £435m (Q322 YTD: £103m loss) mainly driven by lower costs of hedging and the non-repeat of fair value losses on leverage finance lending net of mark to market gains on related hedges in the prior year

–CC&P income increased 23% to £3,944m

–International Cards and Consumer Bank income increased 28% to £2,625m reflecting higher cards balances and improved margins, including the Gap portfolio acquisition in Q222

–Private Bank income increased 21% to £884m, due to the transfer of WM&I from Barclays UK, client balance growth and improved margins

–Payments income was stable at £435m (Q322 YTD: £431m) driven by merchant acquiring growth, partially offset by margin compression

•Total operating expenses decreased 8% to £8,559m, and excluding litigation and conduct increased 9% to £8,519m, reflecting investment in the business

–CIB total operating expenses decreased 11% to £6,192m. Operating expenses excluding litigation and conduct charges increased 6% to £6,201m reflecting investment in talent and technology, and the impact of inflation, partially offset by efficiency savings

–CC&P total operating expenses increased 4% to £2,367m. Operating expenses excluding litigation and conduct charges increased 17% to £2,318m, driven by higher investment spend to support growth, mainly in marketing and partnership costs including the Gap portfolio acquisition, the transfer of WM&I from Barclays UK and the impact of inflation, partially offset by efficiency savings

1Q322 YTD included £292m of income gain related to hedging arrangements to manage the risks of the rescission offer in relation to the Over-issuance of Securities.

2Data source: Dealogic for the period covering 1 January to 30 September 2023.

•Credit impairment charges were £1,037m (Q322 YTD: £605m)

–CIB credit impairment charges were £nil (Q322 YTD: £78m) driven by single name charges offset by the benefit of credit protection and the updated macroeconomic scenarios

–CC&P credit impairment charges increased to £1,037m (Q322 YTD: £527m), with delinquencies in US cards in line with pre-pandemic experience, with 30 and 90 day arrears at 2.7% (Q322: 2.0%) and 1.3% (Q322: 0.8%) respectively. The US cards total coverage ratio was 9.7% (December 2022: 8.1%)

•RWAs increased to £259.2bn (December 2022: £254.8bn) due to increased trading activity within CIB since Q422, partially offset by the impact of strengthening of GBP against USD

–RWAs were broadly stable since June 2023, excluding the impact of spot USD appreciation against GBP

•Loss before tax was £433m (Q322 YTD: £446m)

•Total income was an expense of £179m (Q322 YTD: £139m) primarily reflecting hedge accounting and treasury items. The prior year included a one-off gain of £86m from the sale and leaseback of UK data centres, as well as a £74m loss on sale arising from disposals of Barclays' equity stake in Absa Group Limited

•Total operating expenses decreased to £224m (Q322 YTD: £293m) primarily driven by lower litigation and conduct charges

•RWAs were £9.5bn (December 2022: £8.6bn)

•Barclays paid a half-year dividend of 2.7p per share on 15 September 2023, and completed the share buyback of £750m announced at H123 results, bringing the total capital return equivalent to c.7.5p per share

•Barclays is committed to maintaining a balance between a strong capital position, delivering total cash returns to shareholders and investment in the business. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividend as appropriate, including with share buybacks

•The CET1 ratio increased to 14.0% (December 2022: 13.9%) as CET1 capital increased by £1.1bn to £48.0bn (December 2022: £46.9bn) partially offset by an increase in RWAs of £5.4bn to £341.9bn (December 2022: £336.5bn):

–c.130bps increase from attributable profit generated in the period

–c.60bps decrease driven by returns to shareholders including the interim dividend of 2.7p per share paid in September 2023 and £1.3bn of share buybacks announced with FY22 and H123 results. It also includes an accrual towards the FY23 dividend

–c.30bps decrease from other capital movements, including the impact of regulatory change on 1 January 2023 relating to IFRS 9 transitional relief, the impact of the KMC acquisition, and other regulatory capital deductions

–c.30bps decrease as a result of a £7.4bn increase in RWAs primarily driven by increased trading activity within CIB since December 2022

–A £3.2bn decrease in RWAs as a result of foreign exchange movements since December 2022 was broadly offset by a £0.4bn decrease in CET1 capital due to a decrease in the currency translation reserve

•The UK leverage ratio decreased to 5.0% (December 2022: 5.3%) primarily due to a £72.4bn increase in leverage exposure to £1,202.4bn (December 2022: £1,130.0bn). This is largely driven by increased trading activity within CIB since December 2022

•The liquidity and funding position remains robust and stable in the period. The liquidity pool increased to £335.0bn (December 2022: £318.0bn) driven by deposit growth. The composition of the liquidity pool is conservative, with 81% held in cash and deposits with central banks and the remainder primarily held in high quality government bonds, materially held at fair value or hedged

•The strength of the funding and liquidity position is supported by a diverse and stable deposit franchise. Total deposits increased to £561.3bn (December 2022: £545.8bn)

•The average1 Liquidity Coverage Ratio (LCR) remained significantly above the 100% regulatory requirement at 159% (December 2022: 156%), equivalent to a surplus of £115.6bn (December 2022: £114.4bn)

•The average2 Net Stable Funding Ratio was 138% (December 2022: 137%), which represents a £165.8bn (December 2022: £155.6bn) surplus above the 100% regulatory requirement

•Wholesale funding outstanding, excluding repurchase agreements, was £186.4bn (December 2022: £184.0bn)

•The Group issued £12.0bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) year to date. The Group has a strong MREL position with a ratio of 33.4%, which is in excess of the regulatory requirement of 29.6% plus a confidential, institution specific, Prudential Regulation Authority (PRA) buffer

•KMC acquisition: on 1 March 2023, Barclays completed the acquisition of UK specialist mortgage lender KMC, including a portfolio of mortgages totalling £2.2bn with an RWA impact of £0.8bn

•Combination of the Private Bank and Barclays UK Wealth business: on 1 May 2023, WM&I was transferred from Barclays UK to CC&P, creating a combined Private Bank and Wealth Management business. The combination seeks to improve customer and client experience and create business synergies:

–The business transferred includes c.£28bn of invested assets, generating annualised income of c.£0.2bn

1Represents average of the last 12 spot month end ratios.

2Represents average of the last four spot quarter end ratios.

1The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

2Refer to pages 33 to 37 for further information on how capital, RWAs and leverage are calculated.

3The Liquidity Coverage Ratio is based on the average of the last 12 spot month end ratios. Prior period LCR comparatives have been updated for consistency.

4Represents average of the last four spot quarter end positions.

1The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.

Analysis of Barclays International
Corporate and Investment Bank			Q323			Q223			Q123						Q422			Q322			Q222			Q122						Q4211
Income statement information			£m			£m			£m						£m			£m			£m			£m						£m
Net interest income			700			856			465						548			606			410			385						432
Net trading income			1,503			1,353			2,437						1,201			1,344			2,738			2,450						774
Net fee, commission and other income			879			953			1,074						827			871			885			1,103						1,426
Total income			3,082			3,162			3,976						2,576			2,821			4,033			3,938						2,632
Operating costs			(2,015)			(1,984)			(2,202)						(1,796)			(2,043)			(1,870)			(1,921)						(1,562)
UK bank levy			—			—			—						(126)			—			—			—						(128)
Litigation and conduct			7			(1)			3						(55)			498			(1,314)			(318)						(59)
Total operating expenses			(2,008)			(1,985)			(2,199)						(1,977)			(1,545)			(3,184)			(2,239)						(1,749)
Other net income			2			1			—						2			—			—			—						1
Profit before impairment			1,076			1,178			1,777						601			1,276			849			1,699						884
Credit impairment releases/(charges)			20			13			(33)						(41)			(46)			(65)			33						73
Profit before tax			1,096			1,191			1,744						560			1,230			784			1,732						957
Attributable profit			721			798			1,209						454			1,015			579			1,316						695
Balance sheet information			£bn			£bn			£bn						£bn			£bn			£bn			£bn						£bn
Loans and advances to customers at amortised cost			87.9			84.8			89.2						90.5			93.6			86.5			79.5						73.4
Loans and advances to banks at amortised cost			9.6			9.0			9.2						8.1			10.2			10.0			9.4						7.6
Debt securities at amortised cost			36.3			35.1			30.7						27.2			36.2			29.3			20.7						19.0
Loans and advances at amortised cost			133.8			128.9			129.1						125.8			140.0			125.8			109.6						100.0
Trading portfolio assets			155.3			165.0			137.6						133.7			126.1			126.7			134.0						146.7
Derivative financial instruments assets			280.4			264.8			256.5						301.6			415.5			343.4			288.7						261.5
Financial assets at fair value through the income statement			238.2			232.1			244.9						210.5			244.6			209.2			203.8						188.1
Cash collateral and settlement balances			135.2			122.5			124.7						106.9			162.6			127.7			131.2						87.2
Other assets			237.2			224.6			230.3						222.6			220.6			237.2			222.5						195.8
Total assets			1,180.1			1,137.9			1,123.1						1,101.1			1,309.4			1,170.0			1,089.8						979.3
Deposits at amortised cost			236.9			225.5			221.0						205.8			229.5			229.5			214.7						189.4
Derivative financial instrument liabilities			268.3			254.5			246.7						288.9			394.2			321.2			277.1						256.4
Risk weighted assets			219.2			216.5			216.8						215.9			230.6			227.6			213.5						200.7
Performance measures
Return on average allocated equity			9.2%			10.0%			15.2%						5.4%			11.9%			7.1%			17.1%						9.7%
Return on average allocated tangible equity			9.2%			10.0%			15.2%						5.4%			11.9%			7.1%			17.1%						9.7%
Average allocated equity (£bn)			31.5			31.8			31.8						33.7			34.0			32.7			30.8						28.7
Average allocated tangible equity (£bn)			31.5			31.8			31.8						33.7			34.0			32.7			30.8						28.7
Cost: income ratio			65%			63%			55%						77%			55%			79%			57%						66%
Loan loss rate (bps)			(6)			(4)			10						13			13			20			(12)						(29)
Net interest margin			3.65%			3.98%			3.95%						3.73%			3.56%			2.88%			2.52%						2.67%
Analysis of total income			£m			£m			£m						£m			£m			£m			£m						£m
FICC			1,147			1,186			1,788						976			1,546			1,529			1,644						546
Equities			675			563			704						440			246			1,411			1,052						501
Global Markets			1,822			1,749			2,492						1,416			1,792			2,940			2,696						1,047
Advisory			80			130			212						197			150			236			185						287
Equity capital markets			62			69			50						40			42			37			47						158
Debt capital markets			233			273			341						243			341			281			416						511
Investment Banking fees			375			472			603						480			533			554			648						956
Corporate lending			172			168			95						(128)			(181)			(47)			125						176
Transaction banking			713			773			786						808			677			586			469						453
Corporate			885			941			881						680			496			539			594						629
Total income			3,082			3,162			3,976						2,576			2,821			4,033			3,938						2,632

1The comparative capital and financial metrics relating to Q421 have been restated to reflect the impact of the Over-issuance of Securities.